论文部分内容阅读
目的探讨血液透析联合血液灌流治疗血液透析患者肾性骨病的临床效果。方法选取86例血液透析肾性骨病患者,按随机数字表法分为两组,每组43例。对照组给予血液透析治疗,观察组给予血液透析及血液灌流联合治疗,对比两组患者的治疗效果。结果观察组治疗有效率为93.75%,高于对照组的72.92%,差异有统计学意义(P<0.05);观察组血液内尿素及血肌酐指标低于对照组,差异有统计学意义(P<0.05);观察组钙元素指标明显高于对照组,磷元素及甲状旁腺激素指标明显低于对照相,差异有统计学意义(P<0.05)。结论血液透析及血液灌流联合治疗血液透析患者肾性骨病效果良好,能有效改善临床症状,降低血液内尿素及血肌酐指标。
Objective To investigate the clinical effect of hemodialysis combined with hemoperfusion on hemodialysis patients with renal osteodystrophy. Methods 86 cases of hemodialysis patients with renal osteodystrophy were divided into two groups according to the random number table method, with 43 cases in each group. The control group was given hemodialysis treatment. The observation group was given hemodialysis and hemoperfusion combined therapy, and the therapeutic effect was compared between the two groups. Results The effective rate of observation group was 93.75%, which was higher than that of control group (72.92%), the difference was statistically significant (P <0.05); the index of blood urea and serum creatinine in observation group was lower than that in control group <0.05). The indexes of calcium in the observation group were significantly higher than those in the control group, and the indexes of phosphorus and parathyroid hormone were significantly lower than those in the control group (P <0.05). Conclusion The combination of hemodialysis and hemoperfusion is effective in treating hemodialysis patients with renal osteodystrophy, which can effectively improve the clinical symptoms and reduce the indexes of blood urea and serum creatinine.